-
25/06/2020
Arecor featured in New Scientist’s Business and Industry 2020 Life Sciences campaign – bringing effective and affordable drugs to market more quickly
-
15/06/2020
Arecor presents positive results for the first phase I clinical trial of AT247, a novel ultra-rapid acting insulin
-
10/06/2020
Arecor announces oral presentation of the first phase I clinical trial of AT247, a novel ultra rapid acting formulation of insulin, at the ADA 80th scientific sessions
-
09/06/2020
Arecor announces launch of new website
-
19/03/2020
Arecor extends multi-product collaboration with clinical stage biotech
-
25/02/2020
Arecor achieves second license milestone payment from global pharmaceutical partner
-
13/02/2020
Arecor signs a new feasibility study agreement with top five pharma company
-
16/01/2020
Arecor to participate at PEPTalk 2020’s Protein Science week in San Diego, CA, USA
-
09/01/2020
Hikma and Arecor announce exclusive agreement to develop and commercialise ready-to-use medicine using Arestat™ technology
